YOUNG KWON - 24 Aug 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Young Kwon, by Brian Lenz as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
24 Aug 2023
Net transactions value
+$97,500
Form type
4
Filing time
24 Aug 2023, 19:53:31 UTC
Previous filing
08 Mar 2023
Next filing
28 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Purchase $97,500 +25,000 +9.9% $3.90 277,401 24 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023, that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date and (ii) 251,586 shares of common stock owned by the reporting person.